Hotchkis & Wiley Capital Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.05M Sell
187,920
-98,920
-34% -$1.84M 0.01% 404
2026
Q1
$4.87M Sell
286,840
-55,560
-16% -$944K 0.02% 386
2025
Q4
$6.43M Buy
342,400
+50,000
+17% +$755K 0.02% 364
2025
Q3
$3.74M Buy
292,400
+21,450
+8% +$322K 0.01% 411
2025
Q2
$4.55M Buy
270,950
+111,000
+69% +$1.5M 0.01% 401
2025
Q1
$2.05M Sell
159,950
-1,800
-1% -$28.9K 0.01% 461
2024
Q4
$2.85M Buy
161,750
+23,600
+17% +$448K 0.01% 449
2024
Q3
$3.16M Buy
+138,150
New +$3.12M 0.01% 440

Other funds holding NRC

Hotchkis & Wiley Capital Management's NRC Position: Q2 2026 in Review

Hotchkis & Wiley Capital Management reduced its NRC Health Common Stock (NRC) stake by 34% in Q2 2026, selling an estimated $1.84M and leaving 187,920 shares worth $4.05M. The position accounts for 0.01% of the portfolio, ranked #404.

Hotchkis & Wiley Capital Management first reported a position in NRC in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.43M in Q4 2025. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Hotchkis & Wiley Capital Management held 187,920 shares of NRC Health Common Stock worth $4.05M as of Q2 2026.
  • Hotchkis & Wiley Capital Management sold 98,920 NRC Health Common Stock shares in Q2 2026, an estimated $1.84M.
  • NRC Health Common Stock made up 0.01% of Hotchkis & Wiley Capital Management's portfolio in Q2 2026, its #404 holding.
  • Hotchkis & Wiley Capital Management first reported a position in NRC Health Common Stock in Q3 2024 and has held it in 8 quarters since.
  • Hotchkis & Wiley Capital Management's NRC Health Common Stock position peaked at $6.43M in Q4 2025.
  • 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.